Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis
- PMID: 27399775
- PMCID: PMC4963842
- DOI: 10.3390/toxins8070209
Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis
Abstract
Infection of foot ulcers is a common, often severe and costly complication in diabetes. Diabetic foot infections (DFI) are mainly polymicrobial, and Staphylococcus aureus is the most frequent pathogen isolated. The numerous virulence factors and toxins produced by S. aureus during an infection are well characterized. However, some particular features could be observed in DFI. The aim of this review is to describe the role of S. aureus in DFI and the implication of its toxins in the establishment of the infection. Studies on this issue have helped to distinguish two S. aureus populations in DFI: toxinogenic S. aureus strains (harboring exfoliatin-, EDIN-, PVL- or TSST-encoding genes) and non-toxinogenic strains. Toxinogenic strains are often present in infections with a more severe grade and systemic impact, whereas non-toxinogenic strains seem to remain localized in deep structures and bone involving diabetic foot osteomyelitis. Testing the virulence profile of bacteria seems to be a promising way to predict the behavior of S. aureus in the chronic wounds.
Keywords: Staphylococcus aureus; diabetic foot infection; toxins.
Figures
Similar articles
-
Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection.Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2235-2246. doi: 10.1007/s10096-020-03984-8. Epub 2020 Jul 18. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32683595 Free PMC article. Review.
-
Virulence Factor Genes in Staphylococcus aureus Isolated From Diabetic Foot Soft Tissue and Bone Infections.Int J Low Extrem Wounds. 2018 Mar;17(1):36-41. doi: 10.1177/1534734618764237. Epub 2018 Mar 22. Int J Low Extrem Wounds. 2018. PMID: 29564946
-
Distribution of edin in Staphylococcus aureus isolated from diabetic foot ulcers.Clin Microbiol Infect. 2013 Sep;19(9):875-80. doi: 10.1111/1469-0691.12084. Epub 2012 Nov 23. Clin Microbiol Infect. 2013. PMID: 23176291
-
The bacteriology of diabetic foot ulcers and infections and incidence of Staphylococcus aureus Small Colony Variants.J Med Microbiol. 2023 Jun;72(6). doi: 10.1099/jmm.0.001716. J Med Microbiol. 2023. PMID: 37326607
-
Epidemiological and Clinical Evidence for the Role of Toxins in S. aureus Human Disease.Toxins (Basel). 2020 Jun 19;12(6):408. doi: 10.3390/toxins12060408. Toxins (Basel). 2020. PMID: 32575633 Free PMC article. Review.
Cited by
-
Epidemiology of Pseudomonas aeruginosa in diabetic foot infections: a global systematic review and meta-analysis.Germs. 2023 Dec 31;13(4):362-372. doi: 10.18683/germs.2023.1406. eCollection 2023 Dec. Germs. 2023. PMID: 38361543 Free PMC article. Review.
-
Proportion of toxin and non-toxin virulence factors of Staphylococcus aureus isolates from diabetic foot infection: a systematic review and meta-analysis.BMC Microbiol. 2024 Jan 3;24(1):1. doi: 10.1186/s12866-023-03142-y. BMC Microbiol. 2024. PMID: 38172669 Free PMC article.
-
Whole genome sequencing and pan-genome analysis of Staphylococcus/Mammaliicoccus spp. isolated from diabetic foot ulcers and contralateral healthy skin of Algerian patients.BMC Microbiol. 2023 Nov 16;23(1):342. doi: 10.1186/s12866-023-03087-2. BMC Microbiol. 2023. PMID: 37974097 Free PMC article.
-
Staphylococcus aureus Adaptation to the Skin in Health and Persistent/Recurrent Infections.Antibiotics (Basel). 2023 Oct 7;12(10):1520. doi: 10.3390/antibiotics12101520. Antibiotics (Basel). 2023. PMID: 37887220 Free PMC article. Review.
-
Diabetes mellitus promotes the nasal colonization of high virulent Staphylococcus aureus through the regulation of SaeRS two-component system.Emerg Microbes Infect. 2023 Dec;12(2):2276335. doi: 10.1080/22221751.2023.2276335. Epub 2023 Nov 8. Emerg Microbes Infect. 2023. PMID: 37882148 Free PMC article.
References
-
- Prompers L., Huijberts M., Schaper N., Apelqvist J., Bakker K., Edmonds M., Holstein P., Jude E., Jirkovska A., Mauricio D., et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51:1826–1834. doi: 10.1007/s00125-008-1089-6. - DOI - PubMed
-
- Lavery L.A., Armstrong D.G., Wunderlich R.P., Tredwell J., Boulton A.J. Diabetic foot syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–1438. doi: 10.2337/diacare.26.5.1435. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
